REGISTERED NUMBER: 07416554 (England and Wales)

Financial Statements for the Year Ended 31 December 2024

for

Yiling Ltd

Page

Company Information

1

Statement of Financial Position

2

Notes to the Financial Statements

3

DIRECTORS:

Ms X Li

C Li

S Zhao

REGISTERED OFFICE:

3rd Floor

9 St Clare Street

London

EC3N 1LQ

REGISTERED NUMBER:

07416554 (England and Wales)

AUDITORS:

Shinewing Wilson Accountancy Limited

Chartered Certified Accountants

and Statutory Auditors

9 St Clare Street

London

EC3N 1LQ

CURRENT ASSETS

Debtors

5

-

286

Cash at bank

102,781

112,016

102,781

112,302

CREDITORS

Amounts falling due within one year

6

273,004

268,583

NET CURRENT LIABILITIES

(170,223

)

(156,281

)

TOTAL ASSETS LESS CURRENT LIABILITIES

(170,223

)

(156,281

)

CAPITAL AND RESERVES

Called up share capital

568,500

568,500

Retained earnings

(738,723

)

(724,781

)

SHAREHOLDERS' FUNDS

(170,223

)

(156,281

)

The financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

In accordance with Section 444 of the Companies Act 2006, the Income Statement has not been delivered.

The financial statements were approved by the Board of Directors and authorised for issue on 24 September 2025 and were signed on its behalf by:

C Li - Director

1.	STATUTORY INFORMATION

Yiling Ltd is a private company, limited by shares , registered in England and Wales. The company's registered number and registered office address can be found on the Company Information page.

The presentation currency of the financial statements is the Pound Sterling (£).

2.	ACCOUNTING POLICIES

Basis of preparing the financial statements

These financial statements have been prepared in accordance with Financial Reporting Standard 102 "The Financial Reporting Standard applicable in the UK and Republic of Ireland" including the provisions of Section 1A "Small Entities" and the Companies Act 2006. The financial statements have been prepared under the historical cost convention.

Going concern

The company incurred a loss of 14k during the year and had net current liabilities of £170k at the balance sheet date, which is mainly owed to a fellow subsidiary, no short-term demand on the repayment of the funds is expected to be instructed. The company has received a letter of support from its immediate parent company confirming they agree to provide unconditional financial support to enable the company to meet its obligations as and when they fall due for a minimum 12 months from the date of these financial statements company is able to operate for at least twelve months from the signing of the financial statements. Based on this, the directors believe that the company has adequate resources to continue in operational existence for the foreseeable future and therefore it is appropriate that the company continues to adopt the going concern basis in preparing its financial statements.

Intangible assets

Intangible assets are initially measured at cost. After initial recognition, intangible assets are measured at cost less any accumulated amortisation and any accumulated impairment losses.

Financial instruments

The company has elected to apply the provisions of Section 11 'Basic Financial Instruments' of FRS 102 to all of its financial instruments.

Financial instruments are recognised when the company becomes party to the contractual provisions of the instrument.

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include trade and other receivables and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the financial asset is measured at the present value of the future receipts discounted at a market rate of interest.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

Basic financial liabilities

Basic financial liabilities, including trade and other payables, and loans from group undertakings, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest.

Debt instruments are subsequently carried at amortised cost, using the effective interest method.

Share capital

Financial instruments issued by the company are classified as equity only to the extent that they do not meet the definition of a financial liability or financial asset.

The company's ordinary shares are classified as equity instruments.

Taxation

Taxation for the year comprises current and deferred tax. Tax is recognised in the Income Statement, except to the extent that it relates to items recognised in other comprehensive income or directly in equity.

Current or deferred taxation assets and liabilities are not discounted.

Current tax is recognised at the amount of tax payable using the tax rates and laws that have been enacted or substantively enacted by the statement of financial position date.

Deferred tax

Deferred tax is recognised in respect of all timing differences that have originated but not reversed at the statement of financial position date.

Timing differences arise from the inclusion of income and expenses in tax assessments in periods different from those in which they are recognised in financial statements. Deferred tax is measured using tax rates and laws that have been enacted or substantively enacted by the year end and that are expected to apply to the reversal of the timing difference.

Unrelieved tax losses and other deferred tax assets are recognised only to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits.

Foreign currencies

Assets and liabilities in foreign currencies are translated into sterling at the rates of exchange ruling at the statement of financial position date. Transactions in foreign currencies are translated into sterling at the rate of exchange ruling at the date of transaction. Exchange differences are taken into account in arriving at the operating result.

3.	EMPLOYEES AND DIRECTORS

The average number of employees during the year was 3 (2023 - 3 ) .

4.	INTANGIBLE FIXED ASSETS

Other

intangible

assets

£

COST

At 1 January 2024

and 31 December 2024

50,001

AMORTISATION

At 1 January 2024

and 31 December 2024

50,001

NET BOOK VALUE

At 31 December 2024

-

At 31 December 2023

-

5.

DEBTORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Other debtors

-

286

6.

CREDITORS: AMOUNTS FALLING DUE WITHIN ONE YEAR

31.12.24

31.12.23

£

£

Amounts owed to group undertakings

265,864

261,803

Other creditors

7,140

6,780

273,004

268,583

Amounts owed to group undertakings are unsecured, interest free, have no fixed date of repayment and are repayable on demand.

7.	DISCLOSURE UNDER SECTION 444(5B) OF THE COMPANIES ACT 2006

The Report of the Auditors was unqualified.

Partha Ghosh (Senior Statutory Auditor)

for and on behalf of Shinewing Wilson Accountancy Limited

8.	OTHER FINANCIAL COMMITMENTS

The company had entered into contractual commitments for the registration and MA clone of formulation product In EU and technology transferring amounting to US$600,000. Only US$300,000 has been paid and the balance of US$180,000 and US$120,000 are due to be paid on the grant of EU MA done (Milestone II) and after successful addition of the Yiling Manufacturing site in the dossier (Milestone III) are completed respectively.

9.	RELATED PARTY DISCLOSURES

The company has taken advantage of exemption, under the terms of Financial Reporting Standard 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland', not to disclose related party transactions with wholly owned subsidiaries within the group.

10.	ULTIMATE CONTROLLING PARTY

The immediate parent company is Yiling Pharmaceutical Ltd, a company registered in P. R. China.

The ultimate parent undertaking and the largest group to consolidate these financial statements is Shijiazhuang Yiling Pharmaceutical Co., Ltd., a company registered in P.R. China and copies of the consolidated financial statements can be obtained from No.238 Tianshan Street, High-Tech Development Zone, Shijiazhuang, Hebei, China 050091.

The ultimate controlling party is Mr Y Wu.